Towa Pharmaceutical Co. Ltd. | Mutual Funds
Mutual Funds that own Towa Pharmaceutical Co. Ltd.
Fidelity Northstar Fund
225,000
1.31%
0
0.28%
07/31/2018
Stichting Pensioenfonds ABP (Global Equity Portfolio)
216,351
1.26%
-41,363
0%
03/31/2018
Nomura Asset TOPIX ETF Fund (1306)
151,500
0.88%
2,400
0.02%
07/31/2018
Fidelity Series Intrinsic Opportunities Fund
150,000
0.87%
0
0.08%
04/30/2018
UBAM - SNAM Japan Equity Value
136,400
0.79%
-2,900
1.5%
12/31/2017
Government Pension Fund - Global (The)
132,679
0.77%
-12,801
0%
12/31/2017
Vanguard Total International Stock Index Fund
119,640
0.7%
0
0%
07/31/2018
Daiwa Asset TOPIX Listed ETF (1305)
74,400
0.43%
-100
0.02%
07/31/2018
Nikko Asset Listed Index TOPIX ETF (1308)
68,300
0.4%
0
0.02%
08/20/2018
CREF Stock Account
68,100
0.4%
6,900
0%
03/31/2018
| Address |
2-11 Shinbashi-cho
Kadoma Osaka 571
Japan
|
|
Employees
|
- |
| Website |
http://www.towayakuhin.co.jp |
| Updated |
07/08/2019 |
| Towa Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. Its products include neurological and anti-allergic drugs, cardiovascular and respiratory drugs, gastrointestinal drugs, antibiotics and chemotherapeutic drugs, vitamins; hormone drugs, and other metabolic drugs. The company was founded in June 1951 and is headquartered in Osaka, Japan. |
